Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 54Lung Neoplasms 22Neoplasms 4Neoplasm Metastasis 3Carcinoma 3Breast Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoma 2Hematologic Neoplasms 2Colorectal Neoplasms 2Brain Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Stage IB-IIIA Non-small Cell Lung Carcinoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder) 1Non Small Cell Lung Cancer Metastatic 1NSCLC 1Multiple Endocrine Neoplasia Type 2a 1Mesothelioma 1

Interventions

pembrolizumab 64Cisplatin 44Cetuximab 26Carboplatin 25Paclitaxel 19Magnetic Resonance Spectroscopy 19Radiotherapy, Intensity-Modulated 17Nivolumab 17Radiotherapy 16Specimen Handling 15Docetaxel 14Platinum 131,2-diaminocyclohexaneplatinum II citrate 12Taxes 8Fluorouracil 8Biopsy 8atezolizumab 6Radiation 6(225)Ac-DOTA-c(RGDyK) 6dostarlimab 5cemiplimab 5Ipilimumab 5Immunoglobulin G 5Cyclophosphamide 5Surgical Procedures, Operative 4Standard of Care 4Immune Checkpoint Inhibitors 4Disulfides 4Bevacizumab 4Albumin-Bound Paclitaxel 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × osimertinib × 90 days × Clear all
NCT05785741 2026-04-06

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

DualityBio Inc.

Phase 1/2 Recruiting
1,000 enrolled
BreastHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡